Product Details for: Kisunla

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
350MG/20ML (17.5MG/ML)
Single-Dose Vial
351(a)
Kisunla
Rx
Proper Name
donanemab-azbt
BLA Number
761248
Applicant
Eli Lilly and Company
Original Approval Date
July 2, 2024
Date of First Licensure
RETURN TO SEARCH RESULTS